These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 28676873)

  • 1. Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings.
    Hu T; Lin S; Du R; Fu M; Rao Q; Yin T; Huang Y; Wang G
    Biomater Sci; 2017 Aug; 5(9):1845-1857. PubMed ID: 28676873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are impaired endothelial progenitor cells involved in the processes of late in-stent thrombosis and re-endothelialization of drug-eluting stents?
    Zhao FH; Chen YD; Jin ZN; Lu SZ
    Med Hypotheses; 2008; 70(3):512-4. PubMed ID: 17764856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets.
    Busch R; Strohbach A; Rethfeldt S; Walz S; Busch M; Petersen S; Felix S; Sternberg K
    Acta Biomater; 2014 Feb; 10(2):688-700. PubMed ID: 24148751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An electrospun fiber-covered stent with programmable dual drug release for endothelialization acceleration and lumen stenosis prevention.
    Zhang Y; Wang J; Xiao J; Fang T; Hu N; Li M; Deng L; Cheng Y; Zhu Y; Cui W
    Acta Biomater; 2019 Aug; 94():295-305. PubMed ID: 31195144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of a novel peptide, WKYMVm- and sirolimus-coated stent on re-endothelialization and anti-restenosis.
    Jang EJ; Bae IH; Park DS; Lee SY; Lim KS; Park JK; Shim JW; Sim DS; Jeong MH
    J Mater Sci Mater Med; 2015 Oct; 26(10):251. PubMed ID: 26438653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemocompatibility and anti-fouling behavior of multilayer biopolymers immobilized on gold-thiolized drug-eluting cardiovascular stents.
    Huang LY; Yang MC; Tsou HM; Liu TY
    Colloids Surf B Biointerfaces; 2019 Jan; 173():470-477. PubMed ID: 30326363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface-Degradable Drug-Eluting Stent with Anticoagulation, Antiproliferation, and Endothelialization Functions.
    Hou R; Wu L; Wang J; Yang Z; Tu Q; Zhang X; Huang N
    Biomolecules; 2019 Feb; 9(2):. PubMed ID: 30781704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An asymmetrical dual coating on the stent prepared by ultrasonic atomization.
    Wang J; Ren Y; Huang Y; Du R; Xi Y; Yin T; Wang Y; Zhang D; Chen J; Wang G
    J Biomed Mater Res B Appl Biomater; 2019 Apr; 107(3):825-837. PubMed ID: 30296364
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of REDV/TiO
    Xu X; Wang L; Wang G; Jin Y
    J Biomater Appl; 2017 Jan; 31(6):911-922. PubMed ID: 30208804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atomic layer deposition enhanced grafting of phosphorylcholine on stainless steel for intravascular stents.
    Zhong Q; Yan J; Qian X; Zhang T; Zhang Z; Li A
    Colloids Surf B Biointerfaces; 2014 Sep; 121():238-47. PubMed ID: 25016426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Secreted Matrix Metalloproteinase-9 of Proliferating Smooth Muscle Cells as a Trigger for Drug Release from Stent Surface Polymers in Coronary Arteries.
    Gliesche DG; Hussner J; Witzigmann D; Porta F; Glatter T; Schmidt A; Huwyler J; Meyer Zu Schwabedissen HE
    Mol Pharm; 2016 Jul; 13(7):2290-300. PubMed ID: 27241028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
    Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
    J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemocompatibility of drug-eluting coronary stents coated with sulfonated poly (styrene-block-isobutylene-block-styrene).
    Zhu JZ; Xiong XW; Du R; Jing YJ; Ying Y; Fan XM; Zhu TQ; Zhang RY
    Biomaterials; 2012 Nov; 33(33):8204-12. PubMed ID: 22898183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of promoting effect of a novel Cu-bearing metal stent on endothelialization process from in vitro and in vivo studies.
    Jin S; Qi X; Zhang B; Sun Z; Zhang B; Yang H; Wang T; Zheng B; Wang X; Shi Q; Chen M; Ren L; Yang K; Zhong H
    Sci Rep; 2017 Dec; 7(1):17394. PubMed ID: 29234061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stents Eluting 6-Mercaptopurine Reduce Neointima Formation and Inflammation while Enhancing Strut Coverage in Rabbits.
    Ruiter MS; van Tiel CM; Doornbos A; Marinković G; Strang AC; Attevelt NJ; de Waard V; de Winter RJ; Steendam R; de Vries CJ
    PLoS One; 2015; 10(9):e0138459. PubMed ID: 26389595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrosprayed Montelukast/poly (lactic-co-glycolic acid) particle based coating: A new therapeutic approach towards the prevention of in-stent restenosis.
    Zamani M; Prabhakaran MP; Varshosaz J; Mhaisalkar PS; Ramakrishna S
    Acta Biomater; 2016 Sep; 42():316-328. PubMed ID: 27397493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular endothelial growth factor (VEGF)-eluting stents: in vivo effects on thrombosis, endothelialization and intimal hyperplasia.
    Swanson N; Hogrefe K; Javed Q; Malik N; Gershlick AH
    J Invasive Cardiol; 2003 Dec; 15(12):688-92. PubMed ID: 14660819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In-vitro blood and vascular compatibility of sirolimus-eluting organic/inorganic hybrid stent coatings.
    Jang TS; Cheon KH; Ahn JH; Song EH; Kim HE; Jung HD
    Colloids Surf B Biointerfaces; 2019 Jul; 179():405-413. PubMed ID: 30999119
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct surface modification of metallic biomaterials via tyrosine oxidation aiming to accelerate the re-endothelialization of vascular stents.
    Kakinoki S; Takasaki K; Mahara A; Ehashi T; Hirano Y; Yamaoka T
    J Biomed Mater Res A; 2018 Feb; 106(2):491-499. PubMed ID: 28975703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.